Dublin PR agency providing science dissemination and public communications for EU research consortia across health technology and social policy domains.
Q4 PR Limited is a Dublin-based public relations and communications agency that embeds within EU research consortia as a specialist dissemination and science communication partner. Their core contribution is translating complex scientific outputs into accessible content for public, media, and policy audiences — a role that research-heavy consortia consistently need but rarely have in-house. They have operated across strikingly different domains, from social policy and refugee integration (FOCUS) to advanced optical imaging and cancer diagnostics (PROSCOPE), which signals genuine flexibility as a communications partner rather than narrow sector specialisation. Businesses and scientists would engage them when a consortium needs professional public engagement, stakeholder communication, or dissemination planning beyond what academic partners can provide.
Q4 PR participated in both FOCUS and PROSCOPE as a communications specialist, spanning two entirely different scientific domains — which is characteristic of a dissemination partner rather than a subject-matter expert.
PROSCOPE (2020–2024) required communicating highly technical medical imaging concepts — optical coherence tomography, Raman spectroscopy — to clinical and public audiences.
FOCUS (2019–2022) addressed forced displacement and refugee-host community solidarity, requiring sensitive multi-audience communication across social and political contexts.
Q4 PR entered the H2020 programme through the Society pillar, working on FOCUS (2019–2022), a project centred on refugee integration and community solidarity — territory where policy-facing communication and public narrative matter as much as research outputs. Their next project, PROSCOPE (2020–2024), shifted sharply toward health technology and medical diagnostics, with keywords like optical coherence tomography and colonoscopy indicating a move into science-heavy clinical research communication. With only two projects in the record, the direction is tentative, but it suggests Q4 PR is positioning itself as a general science communications partner rather than a specialist in any one field.
Q4 PR appears to be broadening from social science into health and digital technology communication, which would make them a more versatile dissemination partner for technically complex consortia — if PROSCOPE validates that direction.
Q4 PR has never led an H2020 project — all participation has been as a consortium partner, which is entirely typical for a communications agency brought in for dissemination rather than research leadership. Across two projects they have connected with 24 partners in 9 countries, suggesting they operate comfortably within mid-to-large multi-national consortia. Working with them likely means engaging a responsive execution partner for communication tasks, not a strategic project driver.
Q4 PR has built a pan-European network of 24 consortium partners across 9 countries through just two projects, reflecting the broad multi-national composition of the RIA consortia they joined. Their Irish base gives them natural proximity to Anglophone research networks, though their project partners span the wider EU.
Unlike academic or research institute communications offices, Q4 PR brings dedicated professional PR expertise — media relations, public engagement planning, content production — that most research-led consortia lack internally. Their track record across both social science (FOCUS) and health technology (PROSCOPE) shows they can adapt messaging strategies to very different audiences and subject matters. For a consortium coordinator looking for a proven dissemination partner who already understands EU project reporting obligations, Q4 PR offers relevant experience without the learning curve.
